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Abstract. A simulation model for the production of thrombin in plasma is presented.
Values of the reaction rate constants as determined in purifred systems are used and the
model is tested by comparison of simulations of factor Xa, factor Va and thrombin genera-
tion curves with experimental data obtained in thromboplastin-activated plasma. Simula-
tions of the effect of hirudin indicate that factor V is predominantly actiyated by thrombin
and not by factor Xa. The model predicts a threshold value for the factor Xa production
which, if exceeded, results in explosive and complete activation of prothrombinase. The
dependence ofthis threshold value on different negative feedback reactions, e.g. the inacti-
vation of thrombin and factor Xa by antithrombin III (+ heparin), is investigated. The
threshold value, for control plasma in the range of I - I 0 pM total factor Xa production, can
be raised two orders of magnitude by accelerated inactivation of factor Xa and prothrom-
binase but is hardly affected by a tenfold increase in the rate of thrombin inactivation or by
increased production of activated protein C. This latter effect, however, results in a more
gradual input-response relation between factor Xa input and the extent of prothrombinase
activation.
Introduction
The dual requirements of rapid clot for-
mation in response to vascular lesions and
prevention of spontaneous formation or ex-
pansion of clots suggest an intricate, highly
nonlinear, regulation of thrombin produc-
tion. Extensive research during past decades
has produced detailed knowledge at the mo-
lecular level of the reaction mechanisms in-
volved in the successive activation of the
clotting (co)factors []. Thus emerged the
concept that the explosive amplification of
procoagulant activity is due to the cascade of
successive activations of the serine proteases
with positive feedback through activation of
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cofactors. Assembly with its cofactor, in en-
zyme-cofactor complexes adsorbed to the
procoagulant lipid surface, greatly enhances
the conversion capacity of the enzyme. The
response is limited by localization of the
amplif,red response to the lipid surface at the
site of injury. This localized response is reg-
ulated downward by rather effective scav-
enging of the proteases by antithrombin III
(ATIII), and o2-macroglobulin inactivation
of the cofactors Va and VIIIa by activated
protein C, and inhibition of tissue factor by
extrinsic pathway inhibitor (EPI). Studies of
clotting factor activation in plasma support
the above-mentioned picture and especially
stress the pivotal role ofthe feedback activa-
tion of, e.g., factor V for the amplifrcation of
the response [2-6]. However, apparent dis-
crepancies between data from purified sys-
tems and observations in plasma have also
arisen. In puriflred systems, for instance, it
was shown that factor Xa activates factor V
as effectively as thrombin [7], while it was
concluded from experiments in plasma that
thrombin is the only effective activator of
factor V [5].
Due to the multiple and interacting pro-
tein conversions, the interpretation of data
on thrombin generation in plasma requires a
dynamic model. Therefore a model for the
generation of prothrombinase activity in
plasma was constructed, using reaction rates
derived from experiments in purihed sys-
tems. The response on a transient input of
factor Xa into plasma is considered as a
function of thrombin generation by factor
Xa and prothrombinase, feedback activation
of factor V by thrombin, assembly of pro-
thrombinase, elimination of factor Xa and
thrombin by ATIII, and inactivation of fac-
tor Va by thrombin-activated protein C
(APC). In these respects, it deviates from
earlier models that either did not account for
feedback activation of factor V by prothrom-
bin [8-10] or assumed constant inactivation
of factor Va [1 I ].
Methods
The model
The various mechanisms included in the simula-
tion model are summarized in the following scheme
(see also table 1):
Activation Inactivation
( l a )  F ( t )+  Xa ( lb )  Xa+ATI I I+
Xa-ATIII
(2a)  v  I Iu ,  vu
(2b) v Xa, va
(2c) vuAP9
Va-inactive
( 3 a )  V a + X a e
Va-Xa
(3b)  Va-Xa+ATI I I+
Va + Xa-ATIII
(3c) v"-xu AP9
Va-inactive + Xa
(4a)  I I  Xa ,  I Ia
(4b) II va-Xa , IIu
(ac) IIa + ATIII --+
IIa-ATIII
(5a) c IIu, APC (5b)  APC+APC-inactive
(6) IIa -. ,t tDrlnogen + r lDrln
Generation and Inactivation of Factor Xa. The fac-
tor Xa generation, induced by thromboplastin, is con-
sidered to be a given input F(t) simulated by:
F( t ) :  Qx"  o .exp( -o t ) ,
where Qxu is the total amount factor Xa produced
and o the mono-exponential decay rate associated
with the disappearance of the tissue factor VIIa activ-
ity. The inactivation of factor Xa by ATIII is mod-
elled by a first-order reaction with rate constant ki.
The rate enhancement of this reaction by heparin is
reflected in higher values ofthis parameter [3]. The
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Table l. Reactions rates of the simulation model
Reaction Kinetic parameters References
(1a)
(1b) Ma
Qxu =  20  nM;a= l  m in- r
k i  :0 .25  min- t
estimated. see text
estimated, see text
(2a) M
(2b) M
h"t = 14 min-I;  K' = 72nM
hut - 2.6 min-r; K- = l0nM
7
7
(2c) M k*at= 24 min-r; K- = 20nM l 6
(3a)
(3b)
(3c)
s
F
M
kp : l0 nM-r min-r;
ki  = 0.05 min-r;
h a t : 2 4  m i n - r ;  K . : 2 0 n M
l 5
t 7
t 6
(4a)
(4b)
(4c)
1 8
l 5
l 8
1 5
t 2
M
M
hat  =  2 .3  m 'n- r .K*  =  58 tM
I nM lipid binding sites for factor Xa, Kd : 50 nM
h,t : 2,000 min-r; K. = 210 nM
1 nM lipid binding sites fdr prothrombinase, Kt = 0-01 nM
k i :  1 .3  min- '
(5a) F
(sb) F
k = 0.0014 min-'
ki : 0.35 min-r
estimated, see text
estimated, see text
(6) M K^: 2 pM (corrected for multiple cleavage sites)
a Kinetics:
M: Michaelis-Menten mechanism: y: lq",'E'S/(S + K.)
F: First-order reaction: V: k'E
S = Second-order eaction: V: k'Va'Xa
It was assumed in the simulations that no activated clotting factors were present before addition of the
thromboplastin trigger, i.e. the initial values (t = 0) for the activated factors were set to zero. Initial values for
the unactivated proteins were: prothrombin: I pM; factor V: 30 nM; protein C: 100 n41; fibrinogen: 10 pM-
t 2
values of Qxu and s are obtained by fitting F(t) to the
observed time-activity curve of factor Xa.
Generation and Inactivation ofFactor Va- Activa-
tion of factor V by factor Xa and thrombin are both
included in the model [7, la]. In these reactions, we
must account for competition between prothrombin
and factor V for factor Xa. For two substrates with
concentrations Sr and Sr, competing for the same
enzyme with concentration E, the conversion rate oI'
Sr is given by:
k  u11 'E 'S1/ [S1+K-1(1  +  Su /K . : ) ] ,
where k 
"rt 
is the maximal turnover rate of S1 by the
enzyme and K.r, K62 ilr€ the Michaelis constants of
the conversion ofSl resp. Sz by E. Activated factor V
is degraded by activated protein C (APC).
Generation and Inactivation of Prothrombtnase.
Because initially the factor Xa and factor Va concen-
trations can both be very low (<0.01 nM) and the
second-order association rate constant on small unila-
mellar vesicles is estimated to be ko = l0 ruur-r min-l
[ 5] the assembly rate easily becomes rate limiting.
Therefore, instantaneous equilibrium (quasi steady
state) cannot be assumed and the.transient kinetics
must be included in the model. The inactivation rate
of prothrombinase as a result of factor Va inactiva-
tion by APC is assumed to be identical to the inacti-
vation rate of uncomplexed factor Va. This may
represent an overestimation because some protection
of factor Va by factor Xa has been reported [ 1 6], The
factor Xa complexed in the prothrombinase can be
inactivated by ATIII (+ heparin) although at a about
Willems/Lindhout/Hermens/Hemker
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8006 lower rate than lipid-bound or free factor Xa
l l 7 l .
Generation and Inactivation of Thrombin. The
catalytic effrciency of both factor Xa and the factor
Xa-Va complex increases enormously when bound to
phospholipid [18]. Therefore it is assumed that the
conversion rate is determined by the lipid-bound fac-
tor Xa and Va-Xa and the contribution of free factor
Xa and Va-Xa is neglected. The association to the
lipid generally is rapid [9] and an instantaneous
equilibrium is assumed. The number of bindings sites
then becomes an important determinant of the maxi-
mal prothrombinase activity.
Generation and Inactivation of Activated Protein
C. Both activation ofprotein C by thrombin and inac-
tivation ofAPC are described by apparent first-order
reactions and the rate constants are adjusted by frtting
the factor Va disappearance curve.
Conversion of Fibrinogen by Thrombin This reac-
tion is included to account for the reduction ofthe ac-
tivation rate offactorV by thrombin, caused by the com-
petition of fibrinogen with factor V for thrombin.
The enzymatic conversions and the inactivation
of thrombin and factor Xa by ATIII require at least
two steps, a bimolecular reaction resulting in complex
formation followed by a rateJimiting final step, such
as proteolltic cleavage of the substrate. In order to
avoid unwarranted complexity, these reactions, with
the exception of the assembly of prothrombinase, are
approximated Ly using the quasi-steady-state approx-
imation. This is justified at a time scale of minutes, as
the concentration of the abundant reactant (the sub-
strate or ATIII) in these reactions exceeds 30 nM so
that, even for values as low as 5 X l0-3 nM-l s-l for
the second-order rate constant ofthe association reac-
tion, the half-time for equilibration is less than
0.06 min. Thus the enzymatic reactions are described
by the classical Michaelis-Menten model, and the
inactivation reactions are considered as apparent
first-order reactions.
Numerical Integration. As the set of differential
equations is moderately to very stiff(with hirudin), a
stiffly stable integration routine, the variable-order
variable-step implementation of the backward inte-
gration formula supplied as routine DO2EAF in the
NAG library [20] was employed for numerical calcu-
lation of the solution. The accuracy, target l0-4 nM,
ofthe simulations was checked for several representa-
tive cases by comparison of the results for several val-
ues of the error control Darameter.
Results and Discussion
Generation of Thrombin and Factor Va
in Thromboplastin-Activated Plasma
Figure I shows the response of the com-
plete simulation model on a trigger of tran-
sient factor Xa production. Using the model
parameters presented in table l, the total
amount of factor Xa production (Qxu) and
the decay rate (a) of the factor Xa production
were estimated from the factor Xa time-activ-
ity curve. Then the activation and inactiva-
tion rate constants ofprotein C were adjusted
in order to obtain agreement between model
prediction and observed factor Va activities.
The activation pathway of factor V by factor
Xa proved totally irrelevant in this simula-
tion, values of k""1 between 0 and 3 min-l did
not change the result. Fitting of the thrombin
generation curve revealed that the quantity of
available lipid binding sites for prothrom-
binase had to be limited to I nM (about
0.5 pMlipid), otherwise thrombin peaked too
early. There are no data in the literature on
this parameter but lipid limitation has been
demonstrated in thromboplastin-activated
plasma [21]. The observed trombin curve was
measured by an amidolytic assay (52238) in
which thrombin inactivated by o2-rn&cro-
globulin has about 500/o of the activity of
thrombin and this causes the plateau level of
thrombin activity in the experimental curve.
The lower peak value of the measured throm-
bin activity compared to the simulation is
probably related to clot formation after about
I min and binding of part of the thrombin to
this clot. Beyond these differences, that affect
only the measurement of thrombin activity
and not the parameter fit based on the factor
Va and factor Xa plasma activities, a good
agreement between model and experimental
data is apparent.
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Fig. 1. Model simulations (left panel) and measured plasma activities (right panel) of thrombin, factor Xa
and factor Va. Plasma, activated with l/30 (voVvol) thromboplastin. Experimental data from Pieters [4].
Time Delay of Prothrombin Activation
The time lag of thrombin generation was
found qualitatively to be largely determined
by the product of three reaction rates in-
volved in the feedback activation loop offac-
tor V by thrombin, that is the product ko X
k""t (2a)X k*t (ab) (tabte l). Reduction of
each of these reaction rates results in similar
extensions of the time lag. Reduction of pro-
thrombinase activity appears to cause the
largest delay for a given proportional reduc-
tion of the reacticn rates. The model behav-
ior is relatively insensitive to small changes
in these parameters. The time lag of I min,
as observed in plasma, (frg. 1), required a
reduction of one of these reaction rates by
nearly one order of magnitude, compared to
the values in table 1. However, limitation of
the number of lipid binding sites for pro-
thrombinase to the plausible value of I n-L1
offers a much simpler explanation. Although
this issue requires further experiments, at
the moment the lipid limitation appears the
best explanation, and is incorporated in the
model on the sequel of this paper.
Inhibition of Thrombin by Hirudin:
Factor V in Plasma Is Not Activated by
Factor Xa
The simulations in figure I showed that
the contribution of factor V activation by
factor Xa is unimportant unless the feedback
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loop of activation by thrombin is inter-
rupted, e.g. by efffective scavenging of
thrombin. In a recent report [5], hirudin was
used to this effect in thromboplastin-acti-
vated plasma and from the delayed factor V
activation the conclusion was drawn that
thrombin is the only activator of factor V in
plasma. In order to obtain a quantitative
estimation of factor V activation rate by fac-
tor Xa, these data are analyzed with our
simulation model. Hereto the model was ex-
tended with the bimolecular association
reaction of himdin and thrombin resulting
in the formation of an inactive complex. In
order to obtain a qualitative agreement with
observed data, shown in figure 2, the second
order association rate constant was adjusted
to a value of 2-0nM-t min-1. This is some-
what lower than the reported value of
5.3nM-t min-r [22], but this is consistent
with the sensitivity of this reaction to the
ionic strength also shown in that report. Fig-
ure 2 shows an excellent qualitative agree-
ment between model simulations when it is
assumed that only thrombin contributes to
factor V activation (left panel) and observed
(right panel) plasma activity curves. It ap-
pears that despite the virtually immediate
elimination of thrombin by hirudin, the re-
maining small amounts of thrombin activate
sufficient factor V for the generation of
considerable prothrombinase activity. After
5 min, nearly 500 n 4l thrombin is formed in
the presence of 500 nMhirudin, whereas the
factor Xa uncomplexed with factor Va could
only produce l00nM of thrombin in this
time. This thrombin production results ulti-
mately in nearly complete depletion of hiru-
tin, followed by a rapid rise of plasma
thrombin and complete activation of factor
V. The simulations in figure 3 show that
even a minute catalytic activity (hu, :
0.02 min-t) of factor Xa in factor Va pro-
duction abolishes most of the hirudin-
induced delay in factor V activation and
causes qualitative discrepancies between ex-
perimental data and simulations. Factor-Xa-
mediated activation of factor V causes ear-
lier depletion of hirudin and correspond-
ingly earlier time-activity curves of throm-
bin and factor Va. It is concluded that the
activation rate of factor V by factor Xa in
plasma must be less than 0.02 min-r, that is
a factor of 100 below the value determined
in a purified system [7].
Activation Threshold
In contrast to the situation presented in
figures I and 2, where thrombin generation
is initiated by high factor Xa generations, we
now consider the response to very low factor
Xa generations. For small total factor Xa
generations of frnite duration, the activation
delay may become so long that the factor Xa
concentration has dropped to negligible lev-
els before the appearance offactor Va. Then
the assembly rate of prothrombinase, pro-
portional to the product of the factor Va and
Xa concentrations becomes rate limiting, the
feedback loop is intemrpted and only very
limited activation occurs. This effect was
studied quantitatively by using the simula-
tion model to predict the system response
upon a factor Xa input, F(t) : Qxu.o.
exp(-ot) with a : 1.0 min-1, as a function of
the total factor Xa production (Qg. Lipid
binding sites for factor Xa and prothrom-
binase were kept constant at I nM. The
simulations thus purely reflect the effect of
variable production capacity of factor Xa,
for instance due to different amounts of tis-
sue factor. Figure 4 indeed shows that for
total factor Xa inputs below threshold values
of about 0.5 and 2pM, the activation of
Simulation Model for Thrombin Generation in Plasma I 4 q t ZO3
Fig. 2, Effect of addirion of hirudin on the activa-
tion of thromboplastin-triggered plasma. trft panel
shows model simulations, assuming no activation of
factor V by factor Xa, and the right panel the ob-
served plasma activities of thrombin, factor Xa and
factor Va. Hirudin concentrations were 0. 500 anc
750 nM. Experimental data are from Pieters [5].
Fig.3. The effect ofthe rate offactor V activation
by factor Xa. Indicated are simulations of plasma
activity curves for a hirudin concentration of 7 5O nM
and for values of k"us of factor V activation by factor
Xa equal to 0.0, 0.02, 0.1, 0.5, and 2.6 min-r.
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Fig. 4. Response on low factor Xa generations. The extent of activation of factor V and prothrombin as a
function of total factor Xa production (Q;") for transient factor Xa generation given by F(t) - Qx" o. exp(- at)
with o = l. The reaction rate constants oftable I were used, and total factor Xa production, Qxs, was varied as
indicated. Ultimately activated percentages are indicated. Four cases are considered:
Inactivation rates, min-l
thrombin prothrombinase
0 Control
I Thrombin inhibition
2 Xa inhibition
3 + Prothrombinase inhibition
1 .3
10.0
1 .3
1 . 3
0.25
0.25
10.0
10.0
0.05
0.05
0.05
2.OO
respectively factor V and prothrombin is
negligible, while nearly complete activation
results for values of Qxu exceeding 5 pM
(factor Va) and 20 pM (prothrombin). With
respect to transient inputs ofgiven duration,
the system thus appears to be stable, in con-
trast to systems in which the response cannot
be arbitrarily restrained by limiting the size
of the input. It appears from figure 4 that
such a restrained response results only for
minute inputs. This raises the question
whether the robustness of the system can be
influenced by down-regulation, for instance
by enhancing the inactivation rates offactor
205
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Fig. 5. The effect of the activation rate of protein c. Left panel shows the simulated 
plasma activities of
thrombin, factor Xa and factor va after a trigger of Xa production (Qx. = 20.0 nM) for three activation rates 
(0)
0.0014, (l) 0.0070 and (2) 0.035 min-r. Right panel shows the effect ofthe increased activation rate ofprotein
C on the extent ofprothrombin activation as a function ofthe factor Xa generation. Also shown 
is the input-
response relation for k u, : 0.035 min-r for a steady-state base level of I nr\l APC (3)'
Xa and/or thrombin. Therefore the input-
response relation was also determined for
the following conditions: (l) enhanced inac-
tivation of thrombin with a rate constant of
l0min-l; (2) enhanced factor Xa inactiva-
tion with a rate constant of l0min-t; (3)
both enhanced factor Xa inactivation with a
rate constant of 10 min-l and enhanced pro-
thrombinase inactivation with a rate con-
stant of 2.0 min- l. These values of rate con-
stants are chosen in the range of the ob-
served inactivation rates in the presence of
therapeutic concentrations of standard hepa-
rin [3]. Figure 4 shows that increased throm-
bin inhibition does not affect the input-
response relation for prothrombin activation
and causes only a small shift of this relation
for factor V activation. In contrast, anti-fac-
tor Xa activity increases the robustness of
the system enormously with an upward shift
of the activation thereshold of 2 orders of
magnitude. Additional inhibition of pro-
thrombinase reinforces this effect. This is
seemingly in contrast with the predominant
role of thrombin in the generation of pro-
thrombinase activity as discussed at frg-
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ures 2 and 3, but it should be stressed that
figure 4 presents the situation for very low
factor Xa productions. Furthermore figure 2
already showed factor V activation even
with the very effective thrombin inhibition
by 500 n4lhirudin, resulting in a 100 times
higher inactivation rate of thrombin than
considered in figure 4.
In vivo, the inactivation of factor Va by
APC appears to be an essential regulatory
mechanism because protein C deficiency is
associated with a high incidence of throm-
botic disorders [see Esmon, 23 for a review].
The simulations hitherto were performed
with an extremely low protein C activation
rate (k"u1 : 0.0014 min-r) corresponding to
the situation in plasma where in the absence
of thrombomodulin no effective pathway for
the production of APC exists. In order to
assess the effect ofdown-regulation by effec-
tive APC generation, we determined the de-
pendence of the input-response relation on
the protein C activation rate by thrombin.
The simulations in the left panel of figure 5
show that a 5- or 2S-fold increase ofthe pro-
tein C activation rate has an enormous effect
on the factor Va activity curves but leaves
the thrombin generation curve unaffected.
The right panel of this figure shows, how-
eyer, that the input-response relation be-
comes more gradual for high protein C acti-
vation rates. Up to factor Xa productions of
l0pM, the responses practically coincide
(<20o/o prothrombin activation), but for
higher values of Qxu the prothrombin activa-
tion lags behind for high protein C activa-
tion rates (0.035 min-r). This raises the
question whether the system response for
low values of Qxu can be further limited by
assuming that, in addition to this high acti-
vation rate, a small percentage of protein C
is always present in the activated state. Fig-
ure 5 indeed shows that an amount of l0/o
preexistent APC results in a moderate shift
ofthe threshold value.
General Conclusions
The essential roles of the tremendous pro-
thrombinase activity of the factor Va-Xa-lipid
complex and of the positive feedback activa-
tion of factor V by thrombin are stressed by
the present analysis. This explains the explo-
sive generation of prothrombinase activity
and the absence of any effect of a moderate
increase of the thrombin inactivation rate on
the activation threshold. Only extremely high
inactivation rates, as with hirudin, interfere
sufficiently with the feedback activation of
factor V by thrombin to cause significant
effects. This suggests that reduction of the
gain ofthis feedback loop, for instance by an
immediate reduction of prothrombinase ac-
tivity, as reported for ATIII + heparin in a
purified system [17], could represent an effec-
tive mechanism to reduce the explosivity of
the system. Furthermore this analysis indi-
cates that the possible contribution of factor
Xa to the activation of factor V is negligible
unless the factor Xa concentration is very low
or thrombin inactivation proceeds at unreal-
istic high rate constants, exceeding 200 min-1.
The existence of an activation threshold for
transient factor Xa generation is demon-
strated and this stresses the relevance ofeffec-
tive degradation of the factor-Xa-generating
capacity of tissue factor VIIa [24]. The good
agreement between model predictions and
measured activities in plasma suggests that
the proposed model is essentially valid. How-
ever, the model parameters used were ob-
tained from studies in purifred systems and
further identification of these parameters di-
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rectly from the plasma activation curves is a
next step to consolidate the model.
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